These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 16862606

  • 1. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.
    Mohamed S, Bondi MW, Kasckow JW, Golshan S, Jeste DV.
    Int J Geriatr Psychiatry; 2006 Aug; 21(8):711-8. PubMed ID: 16862606
    [Abstract] [Full Text] [Related]

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 3. Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients.
    Bowie CR, Serper MR, Riggio S, Harvey PD.
    Schizophr Bull; 2005 Jan; 31(1):175-82. PubMed ID: 15888435
    [Abstract] [Full Text] [Related]

  • 4. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
    Fan X, Henderson DC, Nguyen DD, Cather C, Freudenreich O, Evins AE, Borba CP, Goff DC.
    Psychiatry Res; 2008 May 30; 159(1-2):140-6. PubMed ID: 18423611
    [Abstract] [Full Text] [Related]

  • 5. Is quality of life associated with cognitive impairment in schizophrenia?
    Alptekin K, Akvardar Y, Kivircik Akdede BB, Dumlu K, Işik D, Pirinçci F, Yahssin S, Kitiş A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb 30; 29(2):239-44. PubMed ID: 15694230
    [Abstract] [Full Text] [Related]

  • 6. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics.
    Sota TL, Heinrichs RW.
    Compr Psychiatry; 2004 Feb 30; 45(5):415-21. PubMed ID: 15332206
    [Abstract] [Full Text] [Related]

  • 7. Substance abuse and cognitive functioning in schizophrenia.
    Addington J, Addington D.
    J Psychiatry Neurosci; 1997 Mar 30; 22(2):99-104. PubMed ID: 9074303
    [Abstract] [Full Text] [Related]

  • 8. Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.
    Herman M.
    Int J Ment Health Nurs; 2004 Dec 30; 13(4):282-91. PubMed ID: 15660598
    [Abstract] [Full Text] [Related]

  • 9. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA, Morrens M, Sabbe BG.
    Clin Ther; 2008 Sep 30; 30(9):1565-89. PubMed ID: 18840365
    [Abstract] [Full Text] [Related]

  • 10. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS, Chia MY, Chan WY, Sim K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):463-8. PubMed ID: 20109511
    [Abstract] [Full Text] [Related]

  • 11. Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism.
    Allen DN, Goldstein G, Forman SD, Keshavan MS, van Kammen DP, Sanders RD.
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul 16; 13(3):184-7. PubMed ID: 10910089
    [Abstract] [Full Text] [Related]

  • 12. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K, Kettler L, Galletly C.
    Aust N Z J Psychiatry; 2008 Jun 16; 42(6):496-504. PubMed ID: 18465376
    [Abstract] [Full Text] [Related]

  • 13. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R, Balanzá-Martínez V, Sánchez-Moreno J, Martinez-Aran A, Salazar-Fraile J, Selva-Vera G, Rubio C, Mata I, Gómez-Beneyto M, Vieta E.
    J Affect Disord; 2008 Aug 16; 109(3):286-99. PubMed ID: 18289698
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM, Barabash A, Martínez-Vizcaíno V, Tabarés-Seisdedos R, Balanzá-Martínez V, Cabranes-Díaz JA, Baca-Baldomero E, Gómez JL.
    Psychiatry Res; 2009 Oct 30; 169(3):220-8. PubMed ID: 19758705
    [Abstract] [Full Text] [Related]

  • 15. Cognitive functioning related to quality of life in schizophrenia.
    Matsui M, Sumiyoshi T, Arai H, Higuchi Y, Kurachi M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):280-7. PubMed ID: 17884266
    [Abstract] [Full Text] [Related]

  • 16. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB, Anil Yağcioğlu AE, Alptekin K, Turgut TI, Tümüklü M, Yazici MK, Jayathilake K, Tunca Z, Göğüş A, Meltzer HY.
    J Clin Psychiatry; 2006 Dec 01; 67(12):1912-9. PubMed ID: 17194269
    [Abstract] [Full Text] [Related]

  • 17. Reexamination of the characteristics of the deficit schizophrenia patients.
    Tiryaki A, Yazici MK, Anil AE, Kabakçi E, Karaağaoğlu E, Göğüş A.
    Eur Arch Psychiatry Clin Neurosci; 2003 Oct 01; 253(5):221-7. PubMed ID: 14504990
    [Abstract] [Full Text] [Related]

  • 18. Correlates of health-related quality of well-being in older patients with schizophrenia.
    Mittal D, Davis CE, Depp C, Pyne JM, Golshan S, Patterson TL, Jeste DV.
    J Nerv Ment Dis; 2006 May 01; 194(5):335-40. PubMed ID: 16699382
    [Abstract] [Full Text] [Related]

  • 19. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S, Dias VV, Carita AI, Martinez-Arán A.
    Psychiatry Res; 2008 Jul 15; 160(1):55-62. PubMed ID: 18485488
    [Abstract] [Full Text] [Related]

  • 20. The neuropsychological consequences of abstinence among older alcoholics: a cross-sectional study.
    Munro CA, Saxton J, Butters MA.
    Alcohol Clin Exp Res; 2000 Oct 15; 24(10):1510-6. PubMed ID: 11045859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.